Loading…
Treatment of experimentally induced bovine respiratory disease in young calves with a single administration of a combination of florfenicol and meloxicam
This study was designed to evaluate the efficacy of a new florfenicol/meloxicam combination (FMC) in calves with bovine respiratory disease. A total of 90 young calves were challenged via intratracheal deposition of 108 colony-forming units of Mannheimia haemolytica. Data for 84 calves demonstrating...
Saved in:
Published in: | Veterinary record 2018-11, Vol.183 (17), p.535-535 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-b3852-c231dbe079b5a95e5384a139b2fa674a3f1e775475bf21c133a2f50e7604c9163 |
---|---|
cites | cdi_FETCH-LOGICAL-b3852-c231dbe079b5a95e5384a139b2fa674a3f1e775475bf21c133a2f50e7604c9163 |
container_end_page | 535 |
container_issue | 17 |
container_start_page | 535 |
container_title | Veterinary record |
container_volume | 183 |
creator | Achard, Damien Caruso-Vares, Agathe Collin, Jean-François McKelvie, Joanne Reddick, David Ramage, Cliff |
description | This study was designed to evaluate the efficacy of a new florfenicol/meloxicam combination (FMC) in calves with bovine respiratory disease. A total of 90 young calves were challenged via intratracheal deposition of 108 colony-forming units of Mannheimia haemolytica. Data for 84 calves demonstrating a rectal temperature (RT) above 39.5°C and a combined total clinical score (TCS) greater than or equal to 3 were included. Calves were then randomly allocated to one of the three study groups (FMC; florfenicol/flunixin combination (FFC); or saline) and promptly treated. RT and TCS of calves treated with an FMC or FFC were consistently lower than RT and TCS of calves belonging to the control group (P |
doi_str_mv | 10.1136/vr.104795 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2100334316</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2100334316</sourcerecordid><originalsourceid>FETCH-LOGICAL-b3852-c231dbe079b5a95e5384a139b2fa674a3f1e775475bf21c133a2f50e7604c9163</originalsourceid><addsrcrecordid>eNp9kc9u1DAQxi0EokvhwAsgS3CAwxb_iePNEaoWkCohoYVrNHYmxSvHXuxk2zwKb4uXlB6Q4GR79Pu-mfFHyHPOzjiX9dtDOuOs0o16QFaCVWKta80ekhU73quGsRPyJOcdY6JRUjwmJ5Lxjao0X5Gf24QwDhhGGnuKt3tM7vgC72fqQjdZ7KiJBxeQJsx7l2CMaaadywgZC0LnOIVrasEfMNMbN36nQLML1x4pdIMLLo9F5GI4dgBq42BcuC_0PqYeg7PRUwgdHdDHW2dheEoe9eAzPrs7T8nXy4vt-cf11ecPn87fXa2N3CixtkLyziDTjVHQKFRyUwGXjRE91LoC2XPUuiyrTC-45VKC6BVDXbPKNryWp-T14rtP8ceEeWwHly16DwHjlFvBGZOykr_Rl3-huzilUKYrlGikZpqrQr1ZKJtizgn7dl_-FNLcctYe82oPqV3yKuyLO8fJDNjdk38CKoBYgBvncf63U_vtYvvl_SUTtRRF9GoRmWH3n-a_AE44rT0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2129370715</pqid></control><display><type>article</type><title>Treatment of experimentally induced bovine respiratory disease in young calves with a single administration of a combination of florfenicol and meloxicam</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Achard, Damien ; Caruso-Vares, Agathe ; Collin, Jean-François ; McKelvie, Joanne ; Reddick, David ; Ramage, Cliff</creator><creatorcontrib>Achard, Damien ; Caruso-Vares, Agathe ; Collin, Jean-François ; McKelvie, Joanne ; Reddick, David ; Ramage, Cliff</creatorcontrib><description>This study was designed to evaluate the efficacy of a new florfenicol/meloxicam combination (FMC) in calves with bovine respiratory disease. A total of 90 young calves were challenged via intratracheal deposition of 108 colony-forming units of Mannheimia haemolytica. Data for 84 calves demonstrating a rectal temperature (RT) above 39.5°C and a combined total clinical score (TCS) greater than or equal to 3 were included. Calves were then randomly allocated to one of the three study groups (FMC; florfenicol/flunixin combination (FFC); or saline) and promptly treated. RT and TCS of calves treated with an FMC or FFC were consistently lower than RT and TCS of calves belonging to the control group (P<0.001). Moreover, at the end of the study, a high clinical cure rate was observed in calves treated with FMC (100 per cent) or FFC (96.6 per cent) whereas cure was limited for calves receiving saline (29.6 per cent). Interestingly, calves treated with FMC were cured without relapse more rapidly compared with calves treated with FFC (HR=1.76, P<0.05) and with a lower percentage of clinical relapse due to fever (P=0.05). These results underline the high efficacy of the FMC and are in line with the pharmacokinetic properties of florfenicol and meloxicam.</description><identifier>ISSN: 0042-4900</identifier><identifier>EISSN: 2042-7670</identifier><identifier>DOI: 10.1136/vr.104795</identifier><identifier>PMID: 30185471</identifier><language>eng</language><publisher>England: BMJ Publishing Group Limited</publisher><subject>Animals ; Antibiotics ; Antimicrobial agents ; Bacteria ; bovine respiratory disease ; Cattle ; Fever ; florfenicol ; inflammation ; meloxicam ; Pathogens ; Respiratory diseases ; treatment ; Veterinary medicine</subject><ispartof>Veterinary record, 2018-11, Vol.183 (17), p.535-535</ispartof><rights>British Veterinary Association 2018. No commercial re-use. See rights and permissions. Published by BMJ.</rights><rights>British Veterinary Association 2018</rights><rights>2018 British Veterinary Association 2018. No commercial re-use. See rights and permissions. Published by BMJ.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b3852-c231dbe079b5a95e5384a139b2fa674a3f1e775475bf21c133a2f50e7604c9163</citedby><cites>FETCH-LOGICAL-b3852-c231dbe079b5a95e5384a139b2fa674a3f1e775475bf21c133a2f50e7604c9163</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30185471$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Achard, Damien</creatorcontrib><creatorcontrib>Caruso-Vares, Agathe</creatorcontrib><creatorcontrib>Collin, Jean-François</creatorcontrib><creatorcontrib>McKelvie, Joanne</creatorcontrib><creatorcontrib>Reddick, David</creatorcontrib><creatorcontrib>Ramage, Cliff</creatorcontrib><title>Treatment of experimentally induced bovine respiratory disease in young calves with a single administration of a combination of florfenicol and meloxicam</title><title>Veterinary record</title><addtitle>Vet Rec</addtitle><description>This study was designed to evaluate the efficacy of a new florfenicol/meloxicam combination (FMC) in calves with bovine respiratory disease. A total of 90 young calves were challenged via intratracheal deposition of 108 colony-forming units of Mannheimia haemolytica. Data for 84 calves demonstrating a rectal temperature (RT) above 39.5°C and a combined total clinical score (TCS) greater than or equal to 3 were included. Calves were then randomly allocated to one of the three study groups (FMC; florfenicol/flunixin combination (FFC); or saline) and promptly treated. RT and TCS of calves treated with an FMC or FFC were consistently lower than RT and TCS of calves belonging to the control group (P<0.001). Moreover, at the end of the study, a high clinical cure rate was observed in calves treated with FMC (100 per cent) or FFC (96.6 per cent) whereas cure was limited for calves receiving saline (29.6 per cent). Interestingly, calves treated with FMC were cured without relapse more rapidly compared with calves treated with FFC (HR=1.76, P<0.05) and with a lower percentage of clinical relapse due to fever (P=0.05). These results underline the high efficacy of the FMC and are in line with the pharmacokinetic properties of florfenicol and meloxicam.</description><subject>Animals</subject><subject>Antibiotics</subject><subject>Antimicrobial agents</subject><subject>Bacteria</subject><subject>bovine respiratory disease</subject><subject>Cattle</subject><subject>Fever</subject><subject>florfenicol</subject><subject>inflammation</subject><subject>meloxicam</subject><subject>Pathogens</subject><subject>Respiratory diseases</subject><subject>treatment</subject><subject>Veterinary medicine</subject><issn>0042-4900</issn><issn>2042-7670</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kc9u1DAQxi0EokvhwAsgS3CAwxb_iePNEaoWkCohoYVrNHYmxSvHXuxk2zwKb4uXlB6Q4GR79Pu-mfFHyHPOzjiX9dtDOuOs0o16QFaCVWKta80ekhU73quGsRPyJOcdY6JRUjwmJ5Lxjao0X5Gf24QwDhhGGnuKt3tM7vgC72fqQjdZ7KiJBxeQJsx7l2CMaaadywgZC0LnOIVrasEfMNMbN36nQLML1x4pdIMLLo9F5GI4dgBq42BcuC_0PqYeg7PRUwgdHdDHW2dheEoe9eAzPrs7T8nXy4vt-cf11ecPn87fXa2N3CixtkLyziDTjVHQKFRyUwGXjRE91LoC2XPUuiyrTC-45VKC6BVDXbPKNryWp-T14rtP8ceEeWwHly16DwHjlFvBGZOykr_Rl3-huzilUKYrlGikZpqrQr1ZKJtizgn7dl_-FNLcctYe82oPqV3yKuyLO8fJDNjdk38CKoBYgBvncf63U_vtYvvl_SUTtRRF9GoRmWH3n-a_AE44rT0</recordid><startdate>20181103</startdate><enddate>20181103</enddate><creator>Achard, Damien</creator><creator>Caruso-Vares, Agathe</creator><creator>Collin, Jean-François</creator><creator>McKelvie, Joanne</creator><creator>Reddick, David</creator><creator>Ramage, Cliff</creator><general>BMJ Publishing Group Limited</general><general>Blackwell Publishing Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20181103</creationdate><title>Treatment of experimentally induced bovine respiratory disease in young calves with a single administration of a combination of florfenicol and meloxicam</title><author>Achard, Damien ; Caruso-Vares, Agathe ; Collin, Jean-François ; McKelvie, Joanne ; Reddick, David ; Ramage, Cliff</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b3852-c231dbe079b5a95e5384a139b2fa674a3f1e775475bf21c133a2f50e7604c9163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Animals</topic><topic>Antibiotics</topic><topic>Antimicrobial agents</topic><topic>Bacteria</topic><topic>bovine respiratory disease</topic><topic>Cattle</topic><topic>Fever</topic><topic>florfenicol</topic><topic>inflammation</topic><topic>meloxicam</topic><topic>Pathogens</topic><topic>Respiratory diseases</topic><topic>treatment</topic><topic>Veterinary medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Achard, Damien</creatorcontrib><creatorcontrib>Caruso-Vares, Agathe</creatorcontrib><creatorcontrib>Collin, Jean-François</creatorcontrib><creatorcontrib>McKelvie, Joanne</creatorcontrib><creatorcontrib>Reddick, David</creatorcontrib><creatorcontrib>Ramage, Cliff</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest_Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Veterinary record</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Achard, Damien</au><au>Caruso-Vares, Agathe</au><au>Collin, Jean-François</au><au>McKelvie, Joanne</au><au>Reddick, David</au><au>Ramage, Cliff</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of experimentally induced bovine respiratory disease in young calves with a single administration of a combination of florfenicol and meloxicam</atitle><jtitle>Veterinary record</jtitle><addtitle>Vet Rec</addtitle><date>2018-11-03</date><risdate>2018</risdate><volume>183</volume><issue>17</issue><spage>535</spage><epage>535</epage><pages>535-535</pages><issn>0042-4900</issn><eissn>2042-7670</eissn><abstract>This study was designed to evaluate the efficacy of a new florfenicol/meloxicam combination (FMC) in calves with bovine respiratory disease. A total of 90 young calves were challenged via intratracheal deposition of 108 colony-forming units of Mannheimia haemolytica. Data for 84 calves demonstrating a rectal temperature (RT) above 39.5°C and a combined total clinical score (TCS) greater than or equal to 3 were included. Calves were then randomly allocated to one of the three study groups (FMC; florfenicol/flunixin combination (FFC); or saline) and promptly treated. RT and TCS of calves treated with an FMC or FFC were consistently lower than RT and TCS of calves belonging to the control group (P<0.001). Moreover, at the end of the study, a high clinical cure rate was observed in calves treated with FMC (100 per cent) or FFC (96.6 per cent) whereas cure was limited for calves receiving saline (29.6 per cent). Interestingly, calves treated with FMC were cured without relapse more rapidly compared with calves treated with FFC (HR=1.76, P<0.05) and with a lower percentage of clinical relapse due to fever (P=0.05). These results underline the high efficacy of the FMC and are in line with the pharmacokinetic properties of florfenicol and meloxicam.</abstract><cop>England</cop><pub>BMJ Publishing Group Limited</pub><pmid>30185471</pmid><doi>10.1136/vr.104795</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0042-4900 |
ispartof | Veterinary record, 2018-11, Vol.183 (17), p.535-535 |
issn | 0042-4900 2042-7670 |
language | eng |
recordid | cdi_proquest_miscellaneous_2100334316 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Animals Antibiotics Antimicrobial agents Bacteria bovine respiratory disease Cattle Fever florfenicol inflammation meloxicam Pathogens Respiratory diseases treatment Veterinary medicine |
title | Treatment of experimentally induced bovine respiratory disease in young calves with a single administration of a combination of florfenicol and meloxicam |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T02%3A26%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20experimentally%20induced%20bovine%20respiratory%20disease%20in%20young%20calves%20with%20a%20single%20administration%20of%20a%20combination%20of%20florfenicol%20and%20meloxicam&rft.jtitle=Veterinary%20record&rft.au=Achard,%20Damien&rft.date=2018-11-03&rft.volume=183&rft.issue=17&rft.spage=535&rft.epage=535&rft.pages=535-535&rft.issn=0042-4900&rft.eissn=2042-7670&rft_id=info:doi/10.1136/vr.104795&rft_dat=%3Cproquest_cross%3E2100334316%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b3852-c231dbe079b5a95e5384a139b2fa674a3f1e775475bf21c133a2f50e7604c9163%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2129370715&rft_id=info:pmid/30185471&rfr_iscdi=true |